Versteeg Henri H
Department of Internal Medicine/Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Semin Thromb Hemost. 2015 Oct;41(7):747-55. doi: 10.1055/s-0035-1556048. Epub 2015 Sep 26.
Blood coagulation is one of the most profound factors that influence cancer progression. Especially the initiator of coagulation, tissue factor (TF), has been subject to many studies investigating the overlap between coagulation and cancer. It has been known for decades that TF is a risk factor for metastasis, and in mouse models, TF drives metastasis in a coagulation-dependent manner. However, TF also serves as a cellular receptor to drive primary tumor growth and tumor angiogenesis. Nevertheless, recent studies have indicated that TF plays more fundamental roles in cancer biology. TF regulates tumor cell dormancy, is associated with cancer stem cell behavior, epithelial-to-mesenchymal transition, and dictates establishment of the tumor cell premetastatic niche. Especially with regard to these recent roles attributed to TF, no clear idea exists on the exact molecular pathways that are initiated by TF. Finally, TF alternative splicing results in an isoform with different characteristics and functions in cancer. In this review, a summary will be given on both the established as well as the new aspects of TF function in cancer progression.
血液凝固是影响癌症进展的最关键因素之一。特别是凝血启动因子组织因子(TF),已经有许多研究探讨了凝血与癌症之间的重叠关系。数十年来,人们已经知道TF是转移的危险因素,在小鼠模型中,TF以凝血依赖的方式驱动转移。然而,TF还作为一种细胞受体来驱动原发性肿瘤生长和肿瘤血管生成。尽管如此,最近的研究表明TF在癌症生物学中发挥着更基本的作用。TF调节肿瘤细胞休眠,与癌症干细胞行为、上皮-间质转化相关,并决定肿瘤细胞转移前生态位的建立。特别是关于TF的这些最新作用,目前尚不清楚由TF启动的确切分子途径。最后,TF的可变剪接产生了一种在癌症中具有不同特征和功能的异构体。在这篇综述中,将对TF在癌症进展中的既定功能以及新功能进行总结。